Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Clinical trial NCT02988297 · WITHDRAWN

Trial details

NCT number: NCT02988297
Sponsor: Revalesio Corporation
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-10-01
Primary completion: 2028-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.